Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Changes in Tumour Choline Metabolism in Estrogen-receptor Positive / HER2 Negative Breast Cancer Patients Treated With CDK4/6 Inhibitors and Endocrine Therapy

NCT04276272 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04276272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Changes in Tumour Choline Metabolism in Estrogen-receptor Positive / HER2 Negative Breast Cancer Patients Treated With CDK4/6 Inhibitors and Endocrine Therapy
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
February 24, 2022
Completion date
November 3, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

er positive breast cancer, her2-negative breast cancer, metastatic breast cancer